Aligos Therapeutics, Inc. (NASDAQ:ALGS) Financings

Aligos Therapeutics, Inc.

Financings

RaiseDate
Private placement of common stock, pre-funded warrants and accompanying warrants
Announced: about US$105M · US$26.0825 a share · Warrants at US$26.02 · Jefferies +2
Dealers: Jefferies, Piper Sandler, H.C. Wainwright & Co.
Use of proceeds: Advance ALG-000184 into a Phase 2 study in chronic hepatitis B and general corporate purposes
Feb 12, 2025

Read by 6ix AI from the company's releases